AI Terminal
Redcare Pharmacy N.V.
Earnings Release • Jan 24, 2017
6219_rns_2017-01-24_f631bb07-387c-40c2-8e41-46cd0225ea44.html
Earnings Release
Open in ViewerOpens in native device viewer
News Details
Corporate | 24 January 2017 06:58
SHOP APOTHEKE EUROPE continues dynamic growth course in 2016.
DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Preliminary Results/Development of Sales
24.01.2017 / 06:58
The issuer is solely responsible for the content of this announcement.
– NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES,
CANADA, AUSTRALIA OR JAPAN. –
SHOP APOTHEKE EUROPE continues dynamic growth course in 2016.
* Revenues increased by 41 % to EUR 177 million.
* Significant growth in all segments.
* Substantial investment programme launched.
Venlo, January 24, 2017. SHOP APOTHEKE EUROPE N.V., Venlo, Europe’s leading
online OTC pharmacy (OTC = over the counter = non-prescription
medications), has posted revenues of EUR 177 million for the 2016 fiscal
year according to preliminary unaudited results. That’s a year-to-year
revenue increase of 41 % compared to the EUR 126 million posted in 2015.
The rise in operational growth is the result of a substantial increase in
the number of active customers from 1.3 million at the end of 2015 to 1.8
million at the end of 2016 along significant revenue growth in all
segments. Revenues in Germany, currently the company’s biggest segment,
rose 25 % year-to-year to EUR 145 million, from EUR 116 million the
previous year. In the international regions – which include Austria,
France, Belgium, the Netherlands, Spain and Italy – SHOP APOTHEKE EUROPE
has more than tripled its transaction volume, leading to a year-to-year
revenue increase to EUR 30 million (compared to EUR 8 million in 2015). The
third segment, “Germany Services,” which provides web shop services, had a
2016 gross turnover of EUR 4 million prior to the elimination of intragroup
transactions compared to the EUR 3 million posted during fiscal year 2015.
SHOP APOTHEKE EUROPE CFO Dr. Ulrich Wandel provides an initial assessment:
“2016 was a successful year for us. We saw a strong fourth quarter during
which our revenues grew c. 50 % year-to-year to c. EUR 52 million. That
means we were able to meet our ambitious 2016 growth targets; extended our
market leadership in relevant European countries; and further accelerated
our strong growth rates in our new markets. This positive momentum
continues during the first weeks of the new fiscal year 2017.”
To support the company’s international growth, SHOP APOTHEKE EUROPE has
launched an extensive investment programme, starting with the construction
of a high-bay warehouse system at the central logistics site in Venlo, the
Netherlands. Over the next three years the company will invest a total of
EUR 30 million in expanding and upgrading operations and IT at the Venlo
site.
As of December 31, 2016, SHOP APOTHEKE EUROPE employed 324 staff, a
substantial increase from 251 employees a year earlier.
SHOP APOTHEKE EUROPE will publish detailed financial results for the 2016
fiscal year on March 27, 2017, when the company’s consolidated financial
statements will be released.
FINANCIAL CALENDAR 2017
March 27, 2017
Publication of the Full-Year Results 2016
May 15, 2017
Publication of the First Quarter Results 2017
May 16, 2017
Annual General Meeting
July 26, 2017
Publication of the Half-Year Report 2017
November 9, 2017
Publication of the Third Quarter Results 2017
CONFERENCES 2017
May 17-18, 2017
Citi’s European Internet and Digital Conference, London
May 22-24, 2017
Berenberg European Conference USA 2017, Tarrytown, NY
August 29-31, 2017
Commerzbank Conference, Frankfurt
September 6-8, 2017
Citi Global Technology Conference, New York
September 18-20, 2017
Berenberg & Goldman Sachs German Corporate Conference, Munich
ABOUT SHOP APOTHEKE EUROPE
SHOP APOTHEKE EUROPE is Continental Europe’s leading online OTC pharmacy
with a portfolio that focuses on OTC medication and pharmacy-related BPC
products. The Company operates online pharmacies in Germany, Austria,
France, Belgium, Italy, Spain and the Netherlands. In Germany,
TÜV-certified shop-apotheke.com is the market leader in terms of traffic.
SHOP APOTHEKE EUROPE delivers a broad range of more than 100,000 original
products to 1.8 million active customers quickly and at attractive prices.
In addition, SHOP APOTHEKE EUROPE provides comprehensive and consistent
pharmaceutical services.
SHOP APOTHEKE EUROPE generated EUR 177 million in revenues in the financial
year 2016. Headquartered in Venlo (Netherlands), SHOP APOTHEKE EUROPE also
has an administration site for its sales and marketing units in Cologne
(Germany) and an international service center in Tongeren, Belgium. The
online pharmacy has been listed on the regulated market of the Frankfurt
Stock Exchange (Prime Standard) since 13 October 2016.
MEDIA CONTACTS
Trade and public media:
Sven Schirmer
Mobile: +49 152 28 50 63 61
E-Mail: [email protected]
Financial media:
Thomas Schnorrenberg
Mobile: +49 151 46 53 13 17
E-Mail: [email protected]
Investor Relations:
Dr. Ulrich Wandel
Phone: +31 77 850 6117
E-Mail: [email protected]
DISCLAIMER
This announcement does not constitute a public offer or an offer to
subscribe to any securities in any jurisdiction. The offer was made
exclusively on the basis of the company’s securities prospectus that had
been published in connection with the offer. The shares have already been
sold. This announcement contains forward-looking statements that relate to
the future course of business and future financial performance, as well as
future transactions or developments concerning SHOP APOTHEKE EUROPE. The
bases of these statements are current expectations and assumptions of SHOP
APOTHEKE EUROPE’s management, of which a large number are outside SHOPE
APOTHEKE EUROPE’s sphere of influence. These statements are therefore
subject to a variety of risks and uncertainties. If such risks and
uncertainties occur, or if the underlying expectations do not materialize
or the assumptions made are not correct, the actual events, both positive
and negative, may differ materially from those events contained in the
forward-looking statements. SHOP APOTHEKE EUROPE assumes no obligation to
update these forward-looking statements or to correct them in the event of
occurrences or developments other than those anticipated. Such updates or
corrections are not intended.
24.01.2017 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | SHOP APOTHEKE EUROPE N.V. |
| Dirk Hartogweg 14 | |
| 5928 LV Venlo | |
| Netherlands | |
| Phone: | 0800 – 200 800 300 |
| Fax: | 0800 – 90 70 90 20 |
| E-mail: | [email protected] |
| Internet: | www.shop-apotheke-europe.com |
| ISIN: | NL0012044747 |
| WKN: | A2AR94 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| End of News | DGAP News Service |